{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:25:49Z","timestamp":1793834749419,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH117431"],"award-info":[{"award-number":["R01MH117431"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["2I01CX000139"],"award-info":[{"award-number":["2I01CX000139"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005161","name":"Ethel and James Flinn Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1038\/s41380-026-03736-8","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:01:15Z","timestamp":1785798075000},"page":"6723-6745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Next-generation precision medicine for mood disorders: reproducible blood biomarkers enable objective diagnostics, subtyping, and targeted therapeutics"],"prefix":"10.1038","volume":"31","author":[{"given":"J.","family":"Balducci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Germanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1623-2251","authenticated-orcid":false,"given":"SC","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bhagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SM","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Le-Niculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0913-939X","authenticated-orcid":false,"given":"AB","family":"Niculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"3736_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617\u201327.","journal-title":"Arch Gen Psychiatry"},{"key":"3736_CR2","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905\u201317.","journal-title":"Am J Psychiatry"},{"key":"3736_CR3","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","volume":"381","author":"JR Geddes","year":"2013","unstructured":"Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet. 2013;381:1672\u201382.","journal-title":"Lancet"},{"key":"3736_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/mp.2008.11","volume":"14","author":"H Le-Niculescu","year":"2009","unstructured":"Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ, et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry. 2009;14:156\u201374.","journal-title":"Mol Psychiatry"},{"key":"3736_CR5","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41380-021-01061-w","volume":"26","author":"H Le-Niculescu","year":"2021","unstructured":"Le-Niculescu H, Roseberry K, Gill SS, Levey DF, Phalen PL, Mullen J, et al. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs. Mol Psychiatry. 2021;26:2776\u2013804.","journal-title":"Mol Psychiatry"},{"key":"3736_CR6","doi-asserted-by":"publisher","first-page":"e2248593","DOI":"10.1001\/jamanetworkopen.2022.48593","volume":"5","author":"J Fundaun","year":"2022","unstructured":"Fundaun J, Kolski M, Molina-Alvarez M, Baskozos G, Schmid AB. Types and concentrations of blood-based biomarkers in adults with peripheral neuropathies: a systematic review and meta-analysis. JAMA Netw Open. 2022;5:e2248593.","journal-title":"JAMA Netw Open"},{"key":"3736_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41380-024-02758-4","volume":"30","author":"L Colic","year":"2025","unstructured":"Colic L, Sankar A, Goldman DA, Kim JA, Blumberg HP. Towards a neurodevelopmental model of bipolar disorder: a critical review of trait- and state-related functional neuroimaging in adolescents and young adults. Mol Psychiatry. 2025;30:1089\u2013101.","journal-title":"Mol Psychiatry"},{"key":"3736_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-024-07805-2","volume":"633","author":"CJ Lynch","year":"2024","unstructured":"Lynch CJ, Elbau IG, Ng T, Ayaz A, Zhu S, Wolk D, et al. Frontostriatal salience network expansion in individuals in depression. Nature. 2024;633:624\u201333.","journal-title":"Nature"},{"key":"3736_CR9","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/s41591-024-03057-9","volume":"30","author":"L Tozzi","year":"2024","unstructured":"Tozzi L, Zhang X, Pines A, Olmsted AM, Zhai ES, Anene ET, et al. Personalized brain circuit scores identify clinically distinct biotypes in depression and anxiety. Nat Med. 2024;30:2076\u201387.","journal-title":"Nat Med"},{"key":"3736_CR10","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41380-023-02395-3","volume":"29","author":"H Chen","year":"2024","unstructured":"Chen H, Lei Y, Li R, Xia X, Cui N, Chen X, et al. Resting-state EEG dynamic functional connectivity distinguishes non-psychotic major depression, psychotic major depression and schizophrenia. Mol Psychiatry. 2024;29:1088\u201398.","journal-title":"Mol Psychiatry"},{"key":"3736_CR11","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1038\/s41380-023-01988-2","volume":"28","author":"H Yamamoto","year":"2023","unstructured":"Yamamoto H, Lee-Okada HC, Ikeda M, Nakamura T, Saito T, Takata A, et al. GWAS-identified bipolar disorder risk allele in the FADS1\/2 gene region links mood episodes and unsaturated fatty acid metabolism in mutant mice. Mol Psychiatry. 2023;28:2848\u201356.","journal-title":"Mol Psychiatry"},{"key":"3736_CR12","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.1038\/s41380-025-03145-3","volume":"30","author":"C Yu","year":"2025","unstructured":"Yu C, Bakshi A, Agustini B, Walker A, Lin T, Lotfaliany M, et al. Genomic risk prediction for depression in a large prospective study of older adults of European descent. Mol Psychiatry. 2025;30:5865\u201372.","journal-title":"Mol Psychiatry"},{"key":"3736_CR13","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1038\/s41380-025-03019-8","volume":"30","author":"PW Gold","year":"2025","unstructured":"Gold PW, Wong ML. Advances in discerning the mechanisms underlying depression and resiliency: relation to the neurobiology of stress and the effects of antidepressants. Mol Psychiatry. 2025;30:3226\u201339.","journal-title":"Mol Psychiatry"},{"key":"3736_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41386-021-01183-3","volume":"47","author":"AB Niculescu","year":"2022","unstructured":"Niculescu AB, Le-Niculescu H. Precision medicine in psychiatry: biomarkers to the forefront. Neuropsychopharmacology. 2022;47:422\u20133.","journal-title":"Neuropsychopharmacology"},{"key":"3736_CR15","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1038\/s41380-023-01998-0","volume":"28","author":"K Roseberry","year":"2023","unstructured":"Roseberry K, Le-Niculescu H, Levey DF, Bhagar R, Soe K, Rogers J, et al. Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs. Mol Psychiatry. 2023;28:2894\u2013912.","journal-title":"Mol Psychiatry"},{"key":"3736_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03071-y","volume":"14","author":"R Bhagar","year":"2024","unstructured":"Bhagar R, Gill SS, Le-Niculescu H, Yin C, Roseberry K, Mullen J, et al. Next-generation precision medicine for suicidality prevention. Transl Psychiatry. 2024;14:362.","journal-title":"Transl Psychiatry"},{"key":"3736_CR17","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/s41380-024-02433-8","volume":"9","author":"MD Hill","year":"2024","unstructured":"Hill MD, Gill SS, Le-Niculescu H, MacKie O, Bhagar R, Roseberry K, et al. Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomics. Mol Psychiatry. 2024;9:1528\u201349.","journal-title":"Mol Psychiatry"},{"key":"3736_CR18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41380-025-03186-8","volume":"31","author":"R Bhagar","year":"2026","unstructured":"Bhagar R, Le-Niculescu H, Corey SC, Gettelfinger AS, Schmitz M, Ebushi A, et al. Next-generation precision medicine for pain. Mol Psychiatry. 2026;31:869\u201394.","journal-title":"Mol Psychiatry"},{"key":"3736_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41380-024-02636-z","volume":"30","author":"A Ramos","year":"2025","unstructured":"Ramos A, Ishizuka K, Hayashida A, Namkung H, Hayes LN, Srivastava R, et al. Nuclear GAPDH in cortical microglia mediates cellular stress-induced cognitive inflexibility. Mol Psychiatry. 2025;30:363.","journal-title":"Mol Psychiatry"},{"key":"3736_CR20","doi-asserted-by":"crossref","unstructured":"Duchene B, Dixon AE Bidirectional relationships between depression and asthma. Expert Rev Respir Med. 2026;20:523\u201333.","DOI":"10.1080\/17476348.2025.2600111"},{"key":"3736_CR21","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2012.02.009","volume":"148","author":"R Chen","year":"2012","unstructured":"Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Miriami E, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148:1293\u2013307.","journal-title":"Cell"},{"key":"3736_CR22","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/mp.2013.95","volume":"18","author":"H Le-Niculescu","year":"2013","unstructured":"Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N, et al. Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry. 2013;18:1249\u201364.","journal-title":"Mol Psychiatry"},{"key":"3736_CR23","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/mp.2015.112","volume":"20","author":"AB Niculescu","year":"2015","unstructured":"Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N, et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Mol Psychiatry. 2015;20:1266\u201385.","journal-title":"Mol Psychiatry"},{"key":"3736_CR24","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/mp.2016.31","volume":"21","author":"DF Levey","year":"2016","unstructured":"Levey DF, Niculescu EM, Le-Niculescu H, Dainton HL, Phalen PL, Ladd TB, et al. Towards understanding and predicting suicidality in women: biomarkers and clinical risk assessment. Mol Psychiatry. 2016;21:768\u201385.","journal-title":"Mol Psychiatry"},{"key":"3736_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41380-018-0345-5","volume":"24","author":"AB Niculescu","year":"2019","unstructured":"Niculescu AB, Le-Niculescu H, Levey DF, Roseberry K, Soe KC, Rogers J, et al. Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs. Mol Psychiatry. 2019;24:501\u201322.","journal-title":"Mol Psychiatry"},{"key":"3736_CR26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41380-019-0370-z","volume":"25","author":"H Le-Niculescu","year":"2020","unstructured":"Le-Niculescu H, Roseberry K, Levey DF, Rogers J, Kosary K, Prabha S, et al. Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs. Mol Psychiatry. 2020;25:918\u201338.","journal-title":"Mol Psychiatry"},{"key":"3736_CR27","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41380-019-0602-2","volume":"25","author":"AB Niculescu","year":"2020","unstructured":"Niculescu AB, Le-Niculescu H, Roseberry K, Wang S, Hart J, Kaur A, et al. Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs. Mol Psychiatry. 2020;25:1651\u201372.","journal-title":"Mol Psychiatry"},{"key":"3736_CR28","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/mp.2017.128","volume":"22","author":"AB Niculescu","year":"2017","unstructured":"Niculescu AB, Le-Niculescu H, Levey DF, Phalen PL, Dainton HL, Roseberry K, et al. Precision medicine for suicidality: from universality to subtypes and personalization. Mol Psychiatry. 2017;22:1250\u201373.","journal-title":"Mol Psychiatry"},{"key":"3736_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41586-024-08468-9","volume":"639","author":"KS O\u2019Connell","year":"2025","unstructured":"O\u2019Connell KS, Koromina M, van der Veen T, Boltz T, David FS, Yang JMK, et al. Genomics yields biological and phenotypic insights into bipolar disorder. Nature. 2025;639:968\u201375.","journal-title":"Nature"},{"key":"3736_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.psychres.2018.08.034","volume":"269","author":"M Fornaro","year":"2018","unstructured":"Fornaro M, De Berardis D, Anastasia A, Novello S, Fusco A, Cattaneo CI, et al. The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention. Psychiatry Res. 2018;269:658\u201372.","journal-title":"Psychiatry Res"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03736-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:02:10Z","timestamp":1793833330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03736-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["3736"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03736-8","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ABN is listed as inventor on patent applications licensed by MindX Sciences. ABN and AS are co-founders, SMK is a consultant, and MS and JF are full-time employee of MindX Sciences.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}